The funding is split between two Biomedical Research Centres (BRCs). A new BRC, Oxford Health BRC, based at the CLAHRC Oxford’s host NHS organisation, Oxford Health NHS Foundation Trust, and the existing NIHR Oxford BRC, based at Oxford University Hospitals NHS Trust.
BRCs bring together expertise within the NHS with leading research organisations, such as the University of Oxford, in order to translate scientific breakthroughs into life-saving treatments for patients.
Oxford Health will receive £12.8 million funding over the next five years to translate innovative research into better treatments for mental health and dementia.
Stuart Bell CBE, Chair of CLAHRC Oxford’s Management Board and Oxford Health’s Chief Executive, said: “We’re thrilled to host this new NIHR Biomedical Research Centre dedicated to mental health. This award recognises Oxford Health NHS Foundation Trust and the close partnership with the University of Oxford. Together we will be developing close partnerships with others to bring better treatments to the NHS.”
Oxford BRC, established in 2007, will receive £113.7 million to continue and expand its world-class research into conditions such as, cancer, diabetes, genetics, neurology, infection, musculoskeletal, stroke and surgery
CLAHRC Oxford is delighted to see the genesis of this new BRC focussed on mental health and dementia, and the continuation of the great work of the Oxford BRC.
In total the NIHR has announced £816 million funding for ground-breaking health research between 2017 and 2022, split between 20 Biomedical Research Centres (BRCs) across the country.